July is Fragile X Awareness Month: We’re sharing stories from families affected by Fragile X and the pediatric specialists who work with them.
Panorama Sample Report
Read Flipbook
Reports
This stream includes reports providing education on testing of cancer recurrence as well as transplant acceptance or rejection
-
-
Signatera Test Report
Signatera is a bespoke mPCR-NGS assay for detection and quantification of circulating tumor DNA (ctDNA) in the plasma of patients previously diagnosed with cancer.
Read Flipbook
-
Circulating tumor DNA to detect minimal residual disease, response to adjuvant therapy and identify patients at high risk of recurrence
Tarazona N, Henriksen TV, Carbonell-Asins JA, et al. Oral presentation at: American Society of Clinical Oncologist; May 29-31, 2020; Virtual Meeting. Abstract 4009
Read Flipbook
